Back

Robotic-assisted PCI - insights from a monocenter registry

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Coronary intervention: state of the art, complications, and outcomes Outcome ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Jonathan Rilinger

University Heart Center Freiburg-Bad Krozingen, Freiburg (Germany)

5 More presentations in this session

Presentation thumbnail
Peri-interventional ischemic stroke after coronary angiography: a large-scale nationwide cohort analysis from 2006 to 2020
Doctor B. Bay (Hamburg, DE)
Abstract Slides Video
Presentation thumbnail
Coronary perforation incidence and temporal trends (COPIT): systematic review and meta-analysis
Doctor P. Mikhail (Gosford, AU)
Abstract Slides Video
Presentation thumbnail
Ten years survival benefit of CABG or PCI based on individual prediction
Professor P. Serruys (Galway, IE)
Abstract Slides Video
Presentation thumbnail
Stent length and -diameter and long-term clinical outcomes following percutaneous coronary intervention with drug-eluting stent implantation
Ms N. Van Hemert (Utrecht, NL)
Abstract Slides Video
Presentation thumbnail
Clinical outcome up to 2 years after percutaneous coronary intervention in all-comers with concomitant symptomatic peripheral arterial disease: a pooled analysis in 9,204 randomized trial participants
Miss T. Pinxterhuis (Enschede, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Coronary intervention: state of the art, complications, and outcomes

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
Percutaneous coronary intervention using Assisted Robotic TechnologY trial
thumbnail
Congress Presentation
Twelve-month outcome of robotic assisted PCI
thumbnail
Congress Presentation
Precision or tradition? A bayesian meta-analysis of robotic vs. manual percutaneous coronary intervention

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources